Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Surgery
Published in: Journal of Gastrointestinal Surgery 4/2015

01-04-2015 | 2014 SSAT Poster Presentation

Is Antisecretory Therapy After Pancreatoduodenectomy Necessary? Meta-analysis and Contemporary Practices of Pancreatic Surgeons

Authors: James R. Butler, Tyrone Rogers, George Eckart, Gregory R. Martens, Eugene P. Ceppa, Michael G. House, Attila Nakeeb, C. Max Schmidt, Nicholas J. Zyromski

Published in: Journal of Gastrointestinal Surgery | Issue 4/2015

Login to get access

Abstract

Background

Marginal ulcer (MU) is a well-described complication of pancreatoduodenectomy (PD) whose incidence remains unclear. Gastric antisecretory medications likely attenuate the risk of marginal ulceration after PD; however, the true relationship between antisecretory medication and marginal ulceration after PD is not precisely known. The aims of this study were to document the incidence of MU after PD, identify any relationship between MU and gastric antisecretory medication, and survey current practice of MU prophylaxis among experienced pancreatic surgeons.

Methods

the MEDLINE, EMBASE, Cochrane Central Registrar of Controlled Trials, and Cochrane Database of Systematic Reviews databases were searched from their inception to May 2014 for abstracts documenting ulceration after pancreatoduodenectomy. Two reviewers independently graded abstracts for inclusion in this review. Contemporary practice was assessed through a four-question survey distributed globally to 200 established pancreatic surgeons.

Results

After a review of 208 abstracts, 54 studies were graded as relevant. These represented a cohort of 212 patients with marginal ulcer after PD (n = 4794). A meta-analysis of the included references shows mean incidence of ulceration after PD of 2.5 % (confidence interval (CI) 1.8–3.2 %) with a median time to diagnosis of 15.5 months. Pylorus preservation was associated with a MU rate of 2.0 % (CI 1.0–2.9 %), while “classic” PD procedures report an overall rate of 2.6 % (CI 1.6–3.6 %). Documented use of postoperative antisecretory medication was associated with a reduced rate of 1.4 % (CI 0.1–1.7 %). One hundred forty-four of 200 (72 %) surveys were returned, from which it was determined that 92 % of pancreatic surgeons have dealt with this complication, and 86 % routinely prescribe prophylactic antisecretory medication after PD.

Conclusions

The incidence of MU after PD is 2.5 % with a median time to occurrence of 15.5 months postoperatively. Gastric antisecretory medication prescription may affect the incidence of MU. The majority of pancreatic surgeons surveyed have encountered MU after PD; most (86 %) routinely prescribe prophylactic gastric antisecretory medication.
Literature
1.
Dragstedt, L.R., Some Physiologic Principles Involved in Surgical Treatment of Gastric and Duodenal Ulcer Ann. Surg, 1935. 102: p. 563-580
2.
3.
4.
Abdel-Wahab, M., et al., Modified pancreaticoduodenectomy: experience with 81 cases, Wahab modification. Hepatogastroenterology, 2001. 48(42): p. 1572-6.PubMed
5.
Bassi, C., et al., Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. J Gastrointest Surg, 2006. 10(7): p. 1072-80.CrossRefPubMed
6.
Basso, N., et al., Retained antral mucosa in pancreaticoduodenectomy patients. Am J Surg, 1977. 134(2): p. 259-62.CrossRefPubMed
7.
8.
Cameron, J.L., et al., One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg, 1993. 217(5): p. 430-5; discussion 435-8.CrossRefPubMedCentralPubMed
9.
Caronna, R., et al., Functional results of a personal technique of reconstruction after pancreaticoduodenectomy. J Exp Clin Cancer Res, 2003. 22(4 Suppl): p. 187-9.PubMed
10.
De Bernardinis, G., et al., An original reconstructive method after pylorus-preserving pancreatoduodenectomy. Surg Today, 1993. 23(6): p. 481-5.CrossRefPubMed
11.
Fink, A.S., et al., Long-term evaluation of pylorus preservation during pancreaticoduodenectomy. World J Surg, 1988. 12(5): p. 663-70.CrossRefPubMed
12.
Flautner, L., T. Tihanyi, and A. Szecseny, Pancreatogastrostomy: an ideal complement to pancreatic head resection with preservation of the pylorus in the treatment of chronic pancreatitis. Am J Surg, 1985. 150(5): p. 608-11.CrossRefPubMed
13.
14.
Hayashibe, A. and M. Kameyama, The clinical results of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy in consecutive 55 cases. Pancreas, 2007. 35(3): p. 273-5.CrossRefPubMed
15.
16.
Hishinuma, S., et al., Complications after pylorus-preserving pancreatoduodenectomy with gastrointestinal reconstruction by the Imanaga method. J Am Coll Surg, 1998. 186(1): p. 10-6.CrossRefPubMed
17.
Holbrook, R.F., K. Hargrave, and L.W. Traverso, A prospective cost analysis of pancreatoduodenectomy. Am J Surg, 1996. 171(5): p. 508-11.CrossRefPubMed
18.
Hoshal, V.L., Jr., et al., Personal experience with the Whipple operation: outcomes and lessons learned. Am Surg, 2004. 70(2): p. 121-5; discussion 126.PubMed
19.
20.
Jimenez, R.E., et al., Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg, 2000. 231(3): p. 293-300.CrossRefPubMedCentralPubMed
21.
22.
Kim, K.H., et al., Effect of a single layer continuous suture between pancreatic parenchyma and jejunum after duct-to-mucosa anastomosis in pancreaticoduodenectomy: a single surgeon's experiences. Hepatogastroenterology, 2007. 54(77): p. 1368-72.PubMed
23.
Kingsnorth, A.N., J.D. Berg, and M.R. Gray, A novel reconstructive technique for pylorus-preserving pancreaticoduodenectomy: avoidance of early postoperative gastric stasis. Ann R Coll Surg Engl, 1993. 75(1): p. 38-42.PubMedCentralPubMed
24.
Klinkenbijl, J.H., et al., The advantages of pylorus-preserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg, 1992. 216(2): p. 142-5.CrossRefPubMedCentralPubMed
25.
Kozuschek, W., et al., A comparison of long term results of the standard Whipple procedure and the pylorus preserving pancreatoduodenectomy. J Am Coll Surg, 1994. 178(5): p. 443-53.PubMed
26.
27.
Lupo, L.G., et al., Is pyloric function preserved in pylorus-preserving pancreaticoduodenectomy? Eur J Surg, 1998. 164(2): p. 127-32.CrossRefPubMed
28.
Lygidakis, N.J., et al., Reappraisal of a method of reconstruction after pancreatoduodenectomy. Hepatogastroenterology, 2005. 52(64): p. 1077-82.PubMed
29.
Ma, Y.G., et al., Pancreaticoduodenectomy with Roux-Y anastomosis in reconstructing the digestive tract: report of 26 patients. Hepatobiliary Pancreat Dis Int, 2002. 1(4): p. 611-3.PubMed
30.
Matsuno, S., et al., Pancreatic function and rehabilitation after pancreaticoduodenectomy. Jpn J Surg, 1988. 18(1): p. 23-30.CrossRefPubMed
31.
McAfee, M.K., J.A. van Heerden, and M.A. Adson, Is proximal pancreatoduodenectomy with pyloric preservation superior to total pancreatectomy? Surgery, 1989. 105(3): p. 347-51.PubMed
32.
Miedema, B.W., et al., Complications following pancreaticoduodenectomy. Current management. Arch Surg, 1992. 127(8): p. 945-9; discussion 949-50.CrossRefPubMed
33.
Mosca, F., et al., Pancreaticoduodenectomy with pylorus preservation. Ital J Surg Sci, 1984. 14(4): p. 313-20.PubMed
34.
Newman, K.D., et al., Pyloric and gastric preservation with pancreatoduodenectomy. Am J Surg, 1983. 145(1): p. 152-6.CrossRefPubMed
35.
Nishikawa, M., et al., Gastric pH monitoring after pylorus preserving pancreaticoduodenectomy with Billroth I type of reconstruction. J Am Coll Surg, 1994. 179(2): p. 129-34.PubMed
36.
Ohtsuka, T., et al., Postoperative pancreatic exocrine function influences body weight maintenance after pylorus-preserving pancreatoduodenectomy. Am J Surg, 2001. 182(5): p. 524-9.CrossRefPubMed
37.
Oida, T., et al., Gastric marginal ulcer after pancreaticoduodenectomy with pancreaticogastrostomy due to delayed gastric emptying and Helicobacter pylori infection. Hepatogastroenterology, 2012. 59(115): p. 899-902.PubMed
38.
Pannala, R., et al., Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-year experience. Gastrointest Endosc, 2011. 74(2): p. 295-302.CrossRefPubMed
39.
Patel, A.G., et al., Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better? Arch Surg, 1995. 130(8): p. 838-42; discussion 842-3.CrossRefPubMed
40.
Pellegrini, C.A., et al., An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg, 1989. 124(7): p. 778-81.CrossRefPubMed
41.
42.
Riediger, H., et al., Long-term outcome after resection for chronic pancreatitis in 224 patients. J Gastrointest Surg, 2007. 11(8): p. 949-59; discussion 959-60.CrossRefPubMed
43.
Roder, J.D., et al., Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg, 1992. 79(2): p. 152-5.CrossRefPubMed
44.
Ruilova, L.A. and C.D. Hershey, Experience with 21 pancreaticoduodenectomies. Arch Surg, 1976. 111(1): p. 27-30.CrossRefPubMed
45.
Safioleas, M.C., et al., How necessary is vagotomy after pancreaticoduodenectomy and total pancreatectomy. Hepatogastroenterology, 2005. 52(61): p. 251-2.PubMed
46.
Sakaguchi, T., et al., Marginal ulceration after pylorus-preserving pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg, 2000. 7(2): p. 193-7.CrossRefPubMed
47.
Sakorafas, G.H., et al., Long-term results after surgery for chronic pancreatitis. Int J Pancreatol, 2000. 27(2): p. 131-42.CrossRefPubMed
48.
Schmidt, U., et al., Quality of life and functional long-term outcome after partial pancreatoduodenectomy: pancreatogastrostomy versus pancreatojejunostomy. Ann Surg Oncol, 2005. 12(6): p. 467-72.CrossRefPubMed
49.
50.
Shan, Y.S., et al., Reconsideration of delayed gastric emptying in pancreaticoduodenectomy. World J Surg, 2005. 29(7): p. 873-9; discussion 880.CrossRefPubMed
51.
Shinchi, H., et al., Gastric acidity following pancreaticogastrostomy with pylorus-preserving pancreaticoduodenectomy. World J Surg, 2000. 24(1): p. 86-90; discussion 90-1.CrossRefPubMed
52.
Shyr, Y.M., et al., Non-stented pancreaticogastrostomy after pylorus-preserving pancreaticoduodenectomy. Zhonghua Yi Xue Za Zhi (Taipei), 2002. 65(6): p. 254-9.
53.
Tanaka, T., Y. Matsugu, and Y. Fukuda, Use of ultrasonically activated shears improves the safety of pancreaticojejunostomy after pancreaticoduodenectomy. Arch Surg, 2002. 137(11): p. 1258-61.CrossRefPubMed
54.
Traverso, L.W. and R.A. Kozarek, Pancreatoduodenectomy for chronic pancreatitis: anatomic selection criteria and subsequent long-term outcome analysis. Ann Surg, 1997. 226(4): p. 429-35; discussion 435-8.CrossRefPubMedCentralPubMed
55.
56.
Wu, J.M., et al., Reflux esophagitis and marginal ulcer after pancreaticoduodenectomy. J Gastrointest Surg, 2011. 15(5): p. 824-8.CrossRefPubMed
57.
Yamaguchi, K., et al., ERT following IORT improves survival of patients with resectable pancreatic cancer. Hepatogastroenterology, 2005. 52(64): p. 1244-9.PubMed
58.
Elliott, D.W., Effect of lost pancreatic juice on gastric acid and peptic ulcer. Am J Surg, 1974. 127(6): p. 658-62.CrossRefPubMed
59.
Grace, P.A., et al., Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg, 1986. 151(1): p. 141-9.CrossRefPubMed
60.
Crist, D.W., J.V. Sitzmann, and J.L. Cameron, Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg, 1987. 206(3): p. 358-65.CrossRefPubMedCentralPubMed
61.
Traverso, L.W. and W.P. Longmire, Jr., Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation. Ann Surg, 1980. 192(3): p. 306-10.CrossRefPubMedCentralPubMed
62.
Traverso, L.W. and W.P. Longmire, Jr., Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet, 1978. 146(6): p. 959-62.PubMed
63.
K, W., Carcinoma of the ampula of Vater: sucessful radical resection. Br J Surg, 1944. 31: p. 368-373.
64.
Pearlman, N.W., et al., Acid and gastrin levels following pyloric-preserving pancreaticoduodenectomy. Arch Surg, 1986. 121(6): p. 661-4.CrossRefPubMed
65.
Sudo, T., et al., Changes in plasma gastrin and secretin levels after pancreaticoduodenectomy. Surg Gynecol Obstet, 1984. 158(2): p. 133-6.PubMed
66.
Takada, T., et al., Postprandial plasma gastrin and secretin concentrations after a pancreatoduodenectomy. A comparison between a pylorus-preserving pancreatoduodenectomy and the Whipple procedure. Ann Surg, 1989. 210(1): p. 47-51.CrossRefPubMedCentralPubMed
67.
Gumbs, A.A., A.J. Duffy, and R.L. Bell, Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis, 2006. 2(4): p. 460-3.CrossRefPubMed
68.
Wilson, J.A., et al., Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol, 2006. 101(10): p. 2194-9.CrossRefPubMed
69.
Coblijn, U.K., et al., Development of Ulcer Disease After Roux-en-Y Gastric Bypass, Incidence, Risk Factors, and Patient Presentation: A Systematic Review. Obes Surg, 2013.
70.
Drepper, M.D., L. Spahr, and J.L. Frossard, Clopidogrel and proton pump inhibitors--where do we stand in 2012? World J Gastroenterol, 2012. 18(18): p. 2161-71.CrossRefPubMedCentralPubMed
71.
Katz, M.H., Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med, 2010. 170(9): p. 747-8.CrossRefPubMed
72.
Lepage C, R.B., Jooste V et al., Continuing rapid increase in esophageal adenocarcinoma in England and Wales. The American Journal of Gastroenterology 2008. 103(11): p. 2694-9.CrossRefPubMed
73.
PJ, R., Could proton pump inhibitors cause cancer? Archives of Internal Medicine, 2010. 170(19): p. 1775-6.
74.
Brunner, G., C. Athmann, and A. Schneider, Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease. Alimentary Pharmacology & Therapeutics, 2012. 36(1): p. 37-47.CrossRef
75.
Fiocca, R., et al., Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial. Aliment Pharmacol Ther, 2012. 36(10): p. 959-71.CrossRefPubMed
Metadata
Title
Is Antisecretory Therapy After Pancreatoduodenectomy Necessary? Meta-analysis and Contemporary Practices of Pancreatic Surgeons
Authors
James R. Butler
Tyrone Rogers
George Eckart
Gregory R. Martens
Eugene P. Ceppa
Michael G. House
Attila Nakeeb
C. Max Schmidt
Nicholas J. Zyromski
Publication date
01-04-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 4/2015
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2765-8

Other articles of this Issue 4/2015

Journal of Gastrointestinal Surgery 4/2015 Go to the issue

2014 SSAT Plenary Presentation

Bariatric Outcomes are Significantly Improved in Hospitals with Fellowship Council-Accredited Bariatric Fellowships

Original Article

A Randomized Trial of Goal Directed vs Standard Fluid Therapy in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

2014 SSAT Plenary Presentation

Readmission and Risk Factors for Readmission Following Esophagectomy for Esophageal Cancer

Original Article

Resection and Reconstruction of the Hepatic Artery for Advanced Perihilar Cholangiocarcinoma: Result of Arterioportal Shunting

Original Article

Laparoscopic Liver Resection for Lesions Adjacent to Major Vasculature: Feasibility, Safety and Oncological Efficiency

Original Article

Segmental Duodenal Resection: Indications, Surgical Techniques and Postoperative Outcomes